Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122979992 | 12297999 | 2 | F | 20160621 | 20160727 | 20160422 | 20160805 | EXP | CA-TAKEDA-2016MPI001552 | TAKEDA | 56.00 | YR | M | Y | 0.00000 | 20160805 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122979992 | 12297999 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Intravenous (not otherwise specified) | 1.3 MG/M2, UNK | N | 21602 | 1.3 | MG/M**2 | INJECTION | ||||||
| 122979992 | 12297999 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | UNK | N | 21602 | INJECTION | ||||||||
| 122979992 | 12297999 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | UNK | N | 21602 | INJECTION | ||||||||
| 122979992 | 12297999 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 122979992 | 12297999 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 122979992 | 12297999 | 6 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 122979992 | 12297999 | 7 | C | LASIX | FUROSEMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 122979992 | 12297999 | 8 | C | LASIX | FUROSEMIDE | 1 | Unknown | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 122979992 | 12297999 | 9 | C | CANDESARTAN | CANDESARTAN | 1 | Unknown | 18 MG, UNK | 0 | 18 | MG | ||||||||
| 122979992 | 12297999 | 10 | C | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | Unknown | 400 MG, BID | 0 | 400 | MG | BID | |||||||
| 122979992 | 12297999 | 11 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 12.5 MG, UNK | 0 | 12.5 | MG | ||||||||
| 122979992 | 12297999 | 12 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG, UNK | 0 | 25 | MG | ||||||||
| 122979992 | 12297999 | 13 | C | TELMISARTAN. | TELMISARTAN | 1 | Unknown | 60 MG, UNK | 0 | 60 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122979992 | 12297999 | 1 | Amyloidosis |
| 122979992 | 12297999 | 4 | Amyloidosis |
| 122979992 | 12297999 | 5 | Amyloidosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122979992 | 12297999 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122979992 | 12297999 | Albuminuria | |
| 122979992 | 12297999 | Blood bilirubin increased | |
| 122979992 | 12297999 | Blood creatinine increased | |
| 122979992 | 12297999 | Blood potassium increased | |
| 122979992 | 12297999 | Brain natriuretic peptide increased | |
| 122979992 | 12297999 | Chest pain | |
| 122979992 | 12297999 | Coronary artery disease | |
| 122979992 | 12297999 | Light chain analysis increased | |
| 122979992 | 12297999 | Off label use | |
| 122979992 | 12297999 | Product use issue | |
| 122979992 | 12297999 | Psoriasis | |
| 122979992 | 12297999 | Quality of life decreased | |
| 122979992 | 12297999 | Troponin increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122979992 | 12297999 | 1 | 201208 | 0 |